Thursday, November 29, 2018

number 1 makes room for ms-13 et al by killing citizens

with
1. absence of  bcg
2. wasting money on silly war on drugs eg el chapo is not guilt
3 slow distribution of morphine producing yeast so you can stay at home and brew
4 humira, enbrel and remicafe cause fisease by failing to increas the level of tnf alpha






CDC says life expectancy down as more Americans die younger due to suicide and drug overdose


Last Updated Nov 29, 2018 4:06 AM EST
NEW YORK -- Suicides and drug overdoses pushed up U.S. deaths last year, and drove a continuing decline in how long Americans are expected to live.
Overall, there were more than 2.8 million U.S. deaths in 2017, or nearly 70,000 more than the previous year, the Centers for Disease Control and Prevention said Thursday. It was the most deaths in a single year since the government began counting more than a century ago.
The increase partly reflects the nation's growing and aging population. But it's deaths in younger age groups -- particularly middle-aged people -- that have had the largest impact on calculations of life expectancy, experts said.
"These sobering statistics are a wake-up call that we are losing too many Americans, too early and too often, to conditions that are preventable," Dr. Robert Redfield, the CDC's director, said in a statement.
The suicide death rate last year was the highest it's been in at least 50 years, according to U.S. government records. There were more than 47,000 suicides, up from a little under 45,000 the year before.






-----Original Message-----
From: Faustman Lab at Mass General Hospital <diabetestrial@partners.org>

Subject: Update from the Faustman lab



Updates from the Faustman Laboratory at Massachusetts General Hospital.

November 15, 2018 

 Dear Friends,

This was a monumental year at the Faustman Lab.  We published long-term data on patients from the BCG clinical trial program who have been followed for at least five years.  The results were published in Nature Vaccines and presented at eh 78th Scientific Sessions of the American Diabetes Association (ADA) as well as the 54th Annual Meeting of the European Association for the Study of Diabetes (EASD).  The positive feedback and media coverage was overwhelming.  EASD even scheduled a press conference to announce the results.  We also published the second edition of our book, BCG, TNF and Autoimmunity, which is based on the third international conference on BCG and autoimmune diseases.  The 150 patient Phase II trial is also proceeding; all 150 patients have received at least two doses of BCG or placebo.   

BCG is a generic vaccine that holds the promise of an affordable treatment option for type 1 diabetics -- for patients of all means.  As you know, we are operating outside the traditional funding models for clinical trials because BCG is a generic drug.  All of our funding comes from private philanthropies and individuals who are impacted by the disease.  We are the open source approach to clinical trials -- a clinical trial by the people for the people.

We have a lot of work to do before we can bring BCG to market with an FDA approved indication for type 1 diabetes.  We are also actively planning and enrolling new trials including a pediatric trial and an Expanded Access IND.  Anything you can do to help us meet our fundraising goals and turn our full attention back to the research is appreciated.

Please follow us on Facebook and Twitter.  Here is a link to the latest newsletter from the lab Fall 2018 Newsletter for the Faustman lab.



With Kind regards,

Signature

Denise L. Faustman, MD, PhD






























MGH emblem
Harvard Emblem
Like us on Facebook

Faustman Lab at Mass General
Massachusetts General Hospital
Charlestown, Massachusetts 02129
diabetestrial@partners.org
617-726-4084
Faustman Lab at Mass General, Massachusetts General Hospital, Building 149, 13th Street, Room 3602 , Charlestown, MA 02129


Sent by diabetestrial@partners.org in collaboration with
Constant Contact



A general decline 

For decades, U.S. life expectancy was on the upswing, rising a few months nearly every year. Now it's trending the other way: It fell in 2015, stayed level in 2016, and declined again last year, the CDC said.
The nation is in the longest period of a generally declining life expectancy since the late 1910s, when World War I and the worst flu pandemic in modern history combined to kill nearly 1 million Americans. Life expectancy in 1918 was 39.
Aside from that, "we've never really seen anything like this," said Robert Anderson, who oversees CDC death statistics.




In the nation's 10 leading causes of death, only the cancer death rate fell in 2017. Meanwhile, there were increases in seven others - suicide, stroke, diabetes, Alzheimer's, flu/pneumonia, chronic lower respiratory diseases and unintentional injuries.
An underlying factor is that the death rate for heart disease -- the nation's No. 1 killer -- has stopped falling. In years past, declines in heart disease deaths were enough to offset increases in some other kinds of death, but no longer, Anderson said.
(The CDC's numbers do sometimes change. This week, CDC officials said they had revised their life expectancy estimate for 2016 after some additional data came in.)















What's driving it?

CDC officials did not speculate about what's behind declining life expectancy, but Dr. William Dietz, a disease prevention expert at George Washington University, sees a sense of hopelessness.




Financial struggles, a widening income gap and divisive politics are all casting a pall over many Americans, he suggested. "I really do believe that people are increasingly hopeless, and that that leads to drug use, it leads potentially to suicide," he said.
Drug overdose deaths also continued to climb, surpassing 70,000 last year, in the midst of the deadliest drug overdose epidemic in U.S. history. The death rate rose 10 percent from the previous year, smaller than the 21 percent jump seen between 2016 and 2017.
That's not quite cause for celebration, said Dr. John Rowe, a professor of health policy and aging at Columbia University.
"Maybe it's starting to slow down, but it hasn't turned around yet," Rowe said. "I think it will take several years."






Accidental drug overdoses account for more than a third of the unintentional injury deaths, and intentional drug overdoses account for about a tenth of the suicides, said Dr. Holly Hedegaard, a CDC injury researcher.

Other findings

The CDC figures are based mainly on a review of 2017 death certificates. The life expectancy figure is based on current death trends and other factors.
The agency also said:
  • A baby born last year in the U.S. is expected to live about 78 years and 7 months, on average. An American born in 2015 or 2016 was expected to live about a month longer, and one born in 2014 about two months longer than that.
  • The suicide rate was 14 deaths per 100,000 people. That's the highest since at least 1975.
  • The percentage of suicides due to drug overdose has been inching downward.
  • Deaths from flu and pneumonia rose by about 6 percent. The 2017-2018 flu season was one of the worst in more than a decade, and some of the deaths from early in that season appeared in the new death dates.
  • West Virginia was once again the state with the highest rate of drug overdose deaths. The CDC did not release state rates for suicides.
  • Death rates for heroin, methadone and prescription opioid painkillers were flat. But deaths from the powerful painkiller fentanyl and its close opioid cousins continued to soar in 2017.

The CDC did not discuss 2017 gun deaths in the reports released Thursday. But earlier CDC reports noted increase rates of suicide by gun and by suffocation or hanging.

No comments:

Post a Comment